Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open label, single-dose, randomized, 2-period, 2-sequence crossover bioequivalence study of pregabalin in healthy Korean male subjects

Trial Profile

Open label, single-dose, randomized, 2-period, 2-sequence crossover bioequivalence study of pregabalin in healthy Korean male subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jan 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Fibromyalgia; Generalised anxiety disorder; Generalised epilepsy; Neuropathic pain; Pain; Partial epilepsies; Postherpetic neuralgia; Postoperative pain; Restless legs syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Jan 2017 New trial record
    • 27 Dec 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
    • 27 Dec 2016 According to the results published in the International Journal of Clinical Pharmacology and Therapeutics, this study was conducted at the Clinical Trials Center of Kyung Hee University Hospital.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top